None listed
Conditions
Interventions
None listed
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adults aged 19 years or older 2) Patients receiving VA-ECMO via femoral cannulation for refractory cardiogenic shock 3) Patients who have provided written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: 1) Patients who, at the time of VA-ECMO initiation, have a prior diagnosis of atherosclerosis obliterans (ASO) or require surgery or intervention due to irreversible lower limb ischemia 2) Patients with a distal perfusion catheter already inserted at the time of VA-ECMO initiation 3) Pregnant women, women within 30 days postpartum, or lactating participants 4) Patients receiving VA-ECMO for indications other than cardiogenic shock (e.g., trauma, hypothermia, drowning, drug overdose, asphyxia, intracranial hemorrhage, etc.) 5) Patients or legal representatives who do not provide consent to participate in the clinical trial 6) Any other medical condition that, in the opinion of the investigator, would preclude full participation in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vascular PW Doppler values during VA-ECMO | — |
Secondary
| Measure | Time frame |
|---|---|
| Distal perfusion catheter insertion;Surgical or percutaneous intervention due to lower limb ischemia;Limb necrosis;Successful VA-ECMO weaning;In-hospital mortality | — |
Countries
Korea, Republic of
Contacts
Public ContactAh-Ram Kim
Asan Medical Center
Outcome results
None listed